ARTICLE | Clinical News
Zenpep: Phase II/III data
November 23, 2009 8:00 AM UTC
A double-blind, crossover, international Phase II/III trial in 76 evaluable patients showed that 35,000 and 140,000 lipase units of once-daily Zenpep delayed-release capsules significantly increased ...